Bolt Biotherapeutics, Inc.
BOLT· Nasdaq
Released Nov 9, 2023, after the close
10-Q filed Nov 9, 2023, 40 days after period end · 0000950170-23-062048
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $2.53M | $2.11M | $752.00K | $0.00 |
| Net Income | -$16.26M | -$21.76M | -$23.40M | -$10.00M |
| EPS Diluted |
Bolt Biotherapeutics, Inc. · CIK 1641281 · Engraved from SEC EDGAR
| -$0.43 |
| -$0.58 |
| -$0.63 |
| -$4.73 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.